login=false 参考文献:Johann Bauersachs , Rudolf A de Boer , Shelley Zieroth. The year in cardiovascular medicine 2023: the top 10 papers in heart failure and cardiomyopathies. Eur Heart J. 2024 Jan 18:ehad878. 医脉通是专业的在线医生平台,“感知世界医学脉搏,助力中国临床决策”是平台的使命。
https://www.nejm.org/doi/10.1056/NEJMoa2209051 Helmut Baumgartner, Bernard Iung, et,al. The year in cardiovascular medicine 2022: the top 10 papers in valvular heart disease. European Heart Journal, 02 January 2023. FOLLOW US 苏州工业园区心血管健康研究院 电话:0512-68295918 邮箱:info@ccahouse....
Cardiovascular Medicine: Enhanced Multimedia CD-ROM Version 2: E.J. Topol, Editor; 1999; $275.00.A 76-year-old woman presents with a 2-day history of left-lower-quadrant pain. A computed tomographic (CT) scan reveals diverticulitis and an incidental 5.6-cm infrarenal abdominal aortic aneurysm...
La créatinine est le produit de dégradation de la créatine stocké dans le muscle et majoritairement éliminé au niveau du rein par filtration glomérulaire.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk 培马贝特通过降低甘油三脂降低心血管风险 原文链接:https://www.nejm.org/doi/10.1056/NEJMoa2210645 发表期刊:New England Journal of Medicine 发表时间:2023.11.24 PROMINENT试验是一项安慰剂对照的随机试验(RCT),旨在检验假设:培马贝特(0.2 mg,每...
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes 司美格鲁肽对非糖尿病肥胖者心血管结局的影响 原文链接:https://www.nejm.org/doi/10.1056/NEJMoa2307563 发表期刊:New England Journal of Medicine 发表时间:2023.11.11 SELECT试验纳入17,604名超重或肥胖(BMI≥27 kg/m2,已确诊ASCVD)的非糖尿...
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk 培马贝特通过降低甘油三脂降低心血管风险 原文链接:https://www.nejm.org/doi/10.1056/NEJMoa2210645 发表期刊:New England Journal of Medicine 发表时间:2023.11.24 PROMINENT试验是一项安慰剂对照的随机试验(RCT),旨在检验假设:培马贝特(0.2 mg,每...
Nicholls, The Year in Cardiovascular Medicine 2020: Coronary Prevention: Looking back on the Year in Cardiovascular Medicine for 2020 in the field of coronary prevention is Professor Ramon Estruch, Dr Luis Ruilope, and Professor Francesco Cosentino. Mark Nicholls meets them, European Heart Journal, ...
Consumer Information Use and Disclaimer: This information should not be used to decide whether or not to take this medicine or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endo...
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes 司美格鲁肽对非糖尿病肥胖者心血管结局的影响 原文链接:https://www.nejm.org/doi/10.1056/NEJMoa2307563 发表期刊:New England Journal of Medicine 发表时间:2023.11.11 SELECT试验纳入...